Pediatrix Medical Group, Inc.
DE ˙ DB ˙ US58502B1061
18,70 € ↑0,20 (1,08%)
2026-06-04
DEL PRIS
SecurityDE:PDC / Pediatrix Medical Group, Inc.
InstitutionBnp Paribas Arbitrage, Sa
Latest Disclosed Ownership157,238 shares
Latest Disclosed Value $ 3,363,321
Bnp Paribas Arbitrage, Sa reports 9.24% increase in ownership of PDC / Pediatrix Medical Group, Inc.

On May 12, 2026 - Bnp Paribas Arbitrage, Sa filed a 13F-HR form disclosing ownership of 157,238 shares of Pediatrix Medical Group, Inc. (DE:PDC) valued at $2,830,284 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 143,944 shares of Pediatrix Medical Group, Inc.. This represents a change in shares of 9.24% during the quarter. The current value of the position is $2,940,351 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Pediatrix Medical Group Equity 58502B106 157,238 13,294 9.24 3,363 9.26 0.0016
2026-02-10 2025-12-31 13F Pediatrix Medical Group Equity 58502B106 143,944 -327,829 -69.49 3,079 -61.05 0.0014
2025-11-13 2025-09-30 13F Pediatrix Medical Group Equity 58502B106 471,773 -4,325 -0.91 7,902 15.66 0.0042
2025-08-14 2025-06-30 13F Pediatrix Medical Group Equity 58502B106 476,098 414,216 669.36 6,832 662.50 0.0039
2025-05-14 2025-03-31 13F Pediatrix Medical Group Equity 58502B106 61,882 27,106 77.94 897 96.49 0.0005
2025-02-14 2024-12-31 13F Pediatrix Medical Group Equity 58502B106 34,776 16,256 87.78 456 113.08 0.0003
2024-11-13 2024-09-30 13F Pediatrix Medical Group Equity 58502B106 18,520 10,843 141.24 215 275.44 0.0001
2024-08-13 2024-06-30 13F Pediatrix Medical Group Equity 58502B106 7,677 -34,051 -81.60 58 -86.36 0.0000
2024-05-01 2024-03-31 13F Pediatrix Medical Group Equity 58502B106 41,728 18,438 79.17 419 93.52 0.0004
2024-02-14 2023-12-31 13F/A-2 Pediatrix Medical Group Equity 58502B106 23,290 -1,899 -7.54 217 -32.50 0.0002
2024-02-07 2023-12-31 13F/A-1 Pediatrix Medical Group Equity 58502B106 23,290 -1,899 217 0.0000
2024-02-07 2023-12-31 13F Pediatrix Medical Group Equity 58502B106 23,290 217
2023-11-14 2023-09-30 13F Pediatrix Medical Group Equity 58502B106 25,189 2,651 11.76 320 0.00 0.0004
2023-08-09 2023-06-30 13F Pediatrix Medical Group Equity 58502B106 22,538 -17,372 -43.53 320 -46.22 0.0004
2023-05-12 2023-03-31 13F PEDIATRIX MEDICAL GROUP EQUITY 58502B106 39,910 14,694 58.27 595 59.09 0.0008
2023-02-14 2022-12-31 13F Pediatrix Medical Group Equity 58502B106 25,216 -64,814 -71.99 375 -74.83 0.0006
2022-11-16 2022-09-30 13F/A-1 Pediatrix Medical Group Equity 58502B106 90,030 41,661 86.13 1,486 46.26 0.0024
2022-11-15 2022-09-30 13F Pediatrix Medical Group Equity 58502B106 90,030 41,661 1,486 0.0004
2022-08-12 2022-06-30 13F Pediatrix Medical Group Equity 58502B106 48,369 -4,862 -9.13 1,016 -18.65 0.0016
2022-05-18 2022-03-31 13F/A-1 MEDNAX Equity 58502B106 53,231 -15,899 -23.00 1,250 -33.60 0.0017
2022-02-09 2021-12-31 13F MEDNAX EQUITY 58502B106 69,130 -94,666 -57.80 1,881 -59.60 0.0027
2021-11-16 2021-09-30 13F/A-1 MEDNAX EQUITY 58502B106 163,796 17,349 11.85 4,657 5.46 0.0066
2021-11-12 2021-09-30 13F MEDNAX EQUITY 58502B106 11,316 -135,131 184 0.0000
2021-08-10 2021-06-30 13F MEDNAX EQUITY 58502B106 146,447 56,774 63.31 4,415 93.39 0.0058
2021-05-07 2021-03-31 13F MEDNAX EQUITY 58502B106 89,673 12,479 16.17 2,284 20.54 0.0033
2021-02-10 2020-12-31 13F MEDNAX EQUITY 58502B106 77,194 65,878 582.17 1,894 929.35 0.0035
2020-10-30 2020-09-30 13F MEDNAX EQUITY 58502B106 11,316 3,232 39.98 184 33.33 0.0003
2020-08-06 2020-06-30 13F MEDNAX EQUITY 58502B106 8,084 -221,300 -96.48 138 -94.83 0.0002
2020-05-13 2020-03-31 13F MEDNAX EQUITY 58502B106 229,384 -167,996 -42.28 2,670 -75.82 0.0055
2020-02-12 2019-12-31 13F MEDNAX EQUITY 58502B106 397,380 383,944 2,857.58 11,043 3,544.55 0.0201
2019-11-07 2019-09-30 13F MEDNAX EQUITY 58502B106 13,436 -41,517 -75.55 304 -78.14 0.0005
2019-07-30 2019-06-30 13F MEDNAX EQUITY 58502B106 54,953 -153,223 -73.60 1,386 -75.50 0.0028
2019-04-25 2019-03-31 13F MEDNAX EQUITY 58502B106 208,176 206,640 13,453.12 5,656 11,212.00 0.0122
2019-02-12 2018-12-31 13F MEDNAX EQUITY 58502B106 1,536 -336,826 -99.55 51 -99.68 0.0001
2018-11-07 2018-09-30 13F MEDNAX EQUITY 58502B106 338,362 -130,546 -27.84 15,788 -22.21 0.0233
2018-07-25 2018-06-30 13F MEDNAX EQUITY 58502B106 468,908 2,412 0.52 20,294 -21.80 0.0338
2018-05-11 2018-03-31 13F MEDNAX EQUITY 58502B106 466,496 436,752 1,468.37 25,951 1,533.17 0.0486
2018-03-05 2017-12-31 13F/A-1 MEDNAX EQUITY 58502B106 29,744 -242,428 -89.07 1,590 -86.46 0.0028
2018-02-01 2017-12-31 13F MEDNAX EQUITY 58502B106 29,744 -242,428 1,590
2017-11-03 2017-09-30 13F MEDNAX STOCK 58502B106 272,172 219,322 414.99 11,736 267.90 0.0287
2017-08-03 2017-06-30 13F MEDNAX STOCK 58502B106 52,850 28,359 115.79 3,191 87.76 0.0096
2017-05-03 2017-03-31 13F MEDNAX STOCK 58502B106 24,491 -2,406 -8.95 1,699 -5.19 0.0045
2017-02-14 2016-12-31 13F MEDNAX STOCK 58502B106 26,897 19,765 277.13 1,793 279.66 0.0084
2016-10-05 2016-09-30 13F * MEDNAX INC COM STOCK 58502B106 7,132 -32,147 -81.84 472 -83.40 0.0019
2016-07-06 2016-06-30 13F * MEDNAX INC COM STOCK 58502B106 39,279 37,235 1,821.67 2,845 2,054.55 0.0128
2016-04-22 2016-03-31 13F * MEDNAX INC COM STOCK 58502B106 2,044 1,352 195.38 132 169.39 0.0006
2016-04-19 2015-12-31 13F/A-1 * MEDNAX INC COM STOCK 58502B106 692 692 0.00 50 0.0002
2016-02-10 2015-12-31 13F * MEDNAX INC COM STOCK 58502B106 692 50
2015-11-13 2015-09-30 13F MEDNAX INC COM STOCK 58502B106 0 -2,626 -100.00 0 -100.00
2015-08-14 2015-06-30 13F MEDNAX INC COM STOCK 58502B106 2,626 -3,704 -58.52 195 -57.64 0.0005
2015-05-15 2015-03-31 13F * MEDNAX INC COM STOCK 58502B106 6,330 -1,997 -23.98 459 -16.73 0.0013
2015-03-10 2014-12-31 13F/A-1 * MEDNAX INC COM STOCK 58502B106 8,327 5,789 228.09 550 295.68 0.0020
2015-02-11 2014-12-31 13F * MEDNAX INC COM STOCK 58502B106 8,327 550
2014-11-12 2014-09-30 13F * MEDNAX INC COM STOCK 58502B106 2,538 1,676 194.43 139 178.00 0.0001
2014-08-14 2014-06-30 13F/A-1 * MEDNAX INC COM STOCK 58502B106 862 -6,408 -88.14 50 -88.37 0.0000
2014-08-14 2014-06-30 13F MEDNAX INC COM STOCK 58502B106 862 50
2014-05-13 2014-03-31 13F MEDNAX STOCK 58502B106 7,270 5,316 272.06 431 313.46 0.0003
2014-04-02 2013-12-31 13F/A-1 MEDNAX STOCK 58502B106 1,954 1,954 104 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.